The global Genicular Nerve Radiofrequency Ablation market size is predicted to grow from US$ 479 million in 2025 to US$ 1507 million in 2031; it is expected to grow at a CAGR of 21.1% from 2025 to 2031.

RFA is a minimally invasive medical procedure used to alleviate chronic knee pain caused by osteoarthritis. It works by using heat generated from radiofrequency energy to target and deactivate specific sensory nerves responsible for transmitting pain signals from the knee to the brain.

United States market for Genicular Nerve Radiofrequency Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Genicular Nerve Radiofrequency Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Genicular Nerve Radiofrequency Ablation is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Genicular Nerve Radiofrequency Ablation players cover Boston Scientific, Stryker, Abbott, Avanos Medical (coolief), Cosman Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Genicular Nerve Radiofrequency Ablation Industry Forecast” looks at past sales and reviews total world Genicular Nerve Radiofrequency Ablation sales in 2024, providing a comprehensive analysis by region and market sector of projected Genicular Nerve Radiofrequency Ablation sales for 2025 through 2031. With Genicular Nerve Radiofrequency Ablation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genicular Nerve Radiofrequency Ablation industry.

This Insight Report provides a comprehensive analysis of the global Genicular Nerve Radiofrequency Ablation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genicular Nerve Radiofrequency Ablation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genicular Nerve Radiofrequency Ablation market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genicular Nerve Radiofrequency Ablation and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genicular Nerve Radiofrequency Ablation.

This report presents a comprehensive overview, market shares, and growth opportunities of Genicular Nerve Radiofrequency Ablation market by product type, application, key players and key regions and countries.

Segmentation by Type:

    Device
    Service

Segmentation by Application:

    Hospital
    Clinic

This report also splits the market by region:

    Americas

        United States
        Canada
        Mexico
        Brazil

    APAC

        China
        Japan
        Korea
        Southeast Asia
        India
        Australia

    Europe

        Germany
        France
        UK
        Italy
        Russia

    Middle East & Africa

        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

    Boston Scientific
    Stryker
    Abbott
    Avanos Medical (coolief)
    Cosman Medical
    Diros Technology
    Vantage MedTech
    STARmed America
    Beijing Neo Science